Higo Sense, the Warsaw-based digital healthcare provider, has just announced a €5 million Series A funding round led by Cogito Capital Partners with participation from existing early-stage investors, the founders of RTB House.
Founded in 2017, the healthtech startup provides a mobile medical examination device that is supported by a mobile app and an online AI-powered health diagnostic platform. The young company enables physicians to perform high-quality remote patient examinations and patients to perform self-examination, as well as collect diagnostic data prior to or during a telehealth session.
The Higo Sense device is a modular examination tool consisting of a primary device and five extension modules, each dedicated to different functions: thermometer, throat spatula, stethoscope, otoscope and derm hood, enabling both patients and doctors to remotely examine body temperature, throat, heart, lungs, ears, and skin.
Through the mobile app, patients and doctors are guided through the medical examination step-by-step, and they can also have instant access to their health records – making telehealth safe, secure, and easy to operate.
In the midst of a global health crisis, the telemedicine market has been experiencing rapid growth as patients and doctors have increasingly turned to technology for routine medical consultations. With AI-enabled algorithms to drive the platform and through enabling a comprehensive and guided remote examination, Higo Sense significantly expands the range of conditions and symptoms that can now be reliably diagnosed during a telehealth session.
Łukasz Krasnopolski, the Founder and CEO of Higo Sense said: “At Higo, our mission is to deliver both, enhanced patient experience and improved efficiency for healthcare providers. With Higo device and AI-powered health diagnostic platform we enable a remote examination that combines the advantages of telehealth session and in-person appointment”.
Since being founded, Higo Sense has successfully raised €8 million and launched its medical device across Europe. The young company was also one of our finalists at the EU-Startups Summit back in April.
The new funding injection will be used to help the startup continue to expand across Europe, the Middle East, and Asia.